Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antineoplaston A10 in Primary Liver Cancer
NCT00003530Phase 2Terminated
- Sponsor
- Burzynski Research Institute
- Start
- Mar 1977
- Primary completion
- Oct 1999
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of antineoplaston A10, antineoplaston AS2-1 in hepatocellular carcinoma (HCC), sponsored by Burzynski Research Institute. Started Mar 1977; status: terminated.
02
Drugs
antineoplaston A10antineoplaston AS2-1
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00003530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003530.